Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Martins

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Cell Death & Disease|April 5, 2019
Author Correction: Squaramide-based synthetic chloride transporters activate TFEB but block autophagic fluxShaoyi Zhang, Yan Wang, Wei Xie, et al.
Science Translational Medicine|July 21, 2012
Cardiac glycosides exert anticancer effects by inducing immunogenic cell deathLaurie Menger, Erika Vacchelli, Sandy Adjemian, et al.
Cell Death and Differentiation|March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritisUxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cell Death and Differentiation|November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver diseaseOmar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Cell Death and Differentiation|June 3, 2017
NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapyQiuji Wu, Awatef Allouch, Audrey Paoletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2022
ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosisOmar Motiño, Flavia Lambertucci, Gerasimos Anagnostopoulos, et al.
Cell Death & Disease|June 20, 2018
Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous deathIsabelle Martins, Syed Qasim Raza, Laurent Voisin, et al.
Cell Death & Disease|April 6, 2024
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABA<sub>A</sub>Rγ2-derived peptideGerasimos Anagnostopoulos, Ester Saavedra, Flavia Lambertucci, et al.
Cell Death and Differentiation|June 3, 2026
Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulationYan Rong, Flavia Lambertucci, Yaning Yang, et al.
Cell Death & Disease|April 19, 2022
An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA<sub>A</sub> receptorGerasimos Anagnostopoulos, Omar Motiño, Sijing Li, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Cell Death & Disease|April 5, 2019
Author Correction: Squaramide-based synthetic chloride transporters activate TFEB but block autophagic fluxShaoyi Zhang, Yan Wang, Wei Xie, et al.
Science Translational Medicine|July 21, 2012
Cardiac glycosides exert anticancer effects by inducing immunogenic cell deathLaurie Menger, Erika Vacchelli, Sandy Adjemian, et al.
Cell Death and Differentiation|March 14, 2025
Neutralization of acyl CoA binding protein (ACBP) for the experimental treatment of osteoarthritisUxía Nogueira-Recalde, Flavia Lambertucci, Léa Montégut, et al.
Cell Death and Differentiation|November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver diseaseOmar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Cell Death and Differentiation|June 3, 2017
NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapyQiuji Wu, Awatef Allouch, Audrey Paoletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2022
ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosisOmar Motiño, Flavia Lambertucci, Gerasimos Anagnostopoulos, et al.
Cell Death & Disease|June 20, 2018
Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous deathIsabelle Martins, Syed Qasim Raza, Laurent Voisin, et al.
Cell Death & Disease|April 6, 2024
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABA<sub>A</sub>Rγ2-derived peptideGerasimos Anagnostopoulos, Ester Saavedra, Flavia Lambertucci, et al.
Cell Death and Differentiation|June 3, 2026
Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulationYan Rong, Flavia Lambertucci, Yaning Yang, et al.
Cell Death & Disease|April 19, 2022
An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA<sub>A</sub> receptorGerasimos Anagnostopoulos, Omar Motiño, Sijing Li, et al.
Pageof 14